We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$349B
AUM Growth
+$31.6B
Cap. Flow
+$9.53B
Cap. Flow %
2.73%
Top 10 Hldgs %
13.68%
Holding
11,479
New
1,739
Increased
5,110
Reduced
3,129
Closed
997

Sector Composition

Rank Sector Weight
1 Technology 12.23%
2 Financials 6.63%
3 Healthcare 5.96%
4 Consumer Discretionary 5.78%
5 Industrials 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THCA
7376
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
$31K ﹤0.01%
3,019
+336
+13% +$3.41K
HAACU
7377
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$31K ﹤0.01%
3,113
+867
+39% +$8.7K
RCHG
7378
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$31K ﹤0.01%
3,161
+274
+9% +$2.71K
XPOA
7379
DELISTED
DPCM Capital, Inc.
XPOA
$31K ﹤0.01%
3,139
+2,672
+572% +$26.2K
RKLBW
7380
DELISTED
Rocket Lab USA, Inc. Warrant
RKLBW
$31K ﹤0.01%
+8,736
New +$39.9K
JWACU
7381
DELISTED
Jupiter Wellness Acquisition Corp. Unit
JWACU
$31K ﹤0.01%
+3,072
New +$30.8K
AVEO
7382
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$31K ﹤0.01%
6,680
+6,480
+3,240% +$40.2K
AVTX icon
7383
Avalo Therapeutics
AVTX
$1B
$30K ﹤0.01%
+6
New +$36K
BUR icon
7384
Burford Capital
BUR
$942M
$30K ﹤0.01%
2,794
-29,071
-91% -$309K
CIX icon
7385
Comp X International
CIX
$370M
$30K ﹤0.01%
+1,312
New +$29K
CNCR
7386
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$30K ﹤0.01%
1,249
-325
-21% -$9.03K
DARE icon
7387
Dare Bioscience
DARE
$19.9M
$30K ﹤0.01%
1,261
+1,219
+2,902% +$25.1K
EPU icon
7388
iShares MSCI Peru and Global Exposure ETF
EPU
$559M
$30K ﹤0.01%
1,000
-1,978
-66% -$57.3K
FDEM icon
7389
Fidelity Emerging Markets Multifactor ETF
FDEM
$578M
$30K ﹤0.01%
1,175
+75
+7% +$1.94K
FNOV icon
7390
FT Vest US Equity Buffer ETF November
FNOV
$1.23B
$30K ﹤0.01%
767
-380
-33% -$14.6K
GIPR icon
7391
Generation Income Properties
GIPR
$775K
$30K ﹤0.01%
+483
New +$33.1K
CBIO
7392
Crescent Biopharma
CBIO
$610M
$30K ﹤0.01%
+211
New +$38.3K
MERC icon
7393
Mercer International
MERC
$45.2M
$30K ﹤0.01%
2,498
-5,004
-67% -$55.5K
MESO
7394
Mesoblast
MESO
$2.03B
$30K ﹤0.01%
3,086
+2,055
+199% +$23.9K
MYFW icon
7395
First Western Financial
MYFW
$309M
$30K ﹤0.01%
1,001
+896
+853% +$26.8K
MZZ icon
7396
ProShares UltraShort MidCap400
MZZ
$2.41M
$30K ﹤0.01%
1,945
-685
-26% -$11K
NAUT icon
7397
Nautilus Biotechnolgy
NAUT
$113M
$30K ﹤0.01%
5,631
-31,682
-85% -$170K
NNVC icon
7398
NanoViricides
NNVC
$35.7M
$30K ﹤0.01%
8,134
+1,081
+15% +$4.92K
PRTH icon
7399
Priority Technology Holdings
PRTH
$443M
$30K ﹤0.01%
+4,271
New +$26.3K
QSIAW
7400
DELISTED
Quantum-Si Inc Warrant
QSIAW
$30K ﹤0.01%
16,804
+14,695
+697% +$26.3K

Similar funds

UBS Group's Q4 2021 Portfolio in Review

As of Q4 2021, UBS Group held 11,479 positions worth $349B, up 9.9% from $318B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q4 2021 filing shows 1,739 new, 5,110 increased, 3,129 reduced and 997 closed positions. Its largest new stake was Hertz: 1,027,564 shares worth $25.7M. The largest sale was iShares Russell 2000 ETF, an estimated $717M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2021 buy was Hertz: 1,027,564 shares worth $25.7M.
  • UBS Group added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.06B increase.
  • UBS Group's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $717M.
  • UBS Group fully exited Kansas City Southern in Q4 2021, selling an estimated $81.9M.
  • UBS Group's ten largest holdings make up 14% of its $349B portfolio in Q4 2021.
  • UBS Group opened 1,739 new positions and closed 997 in Q4 2021.
  • UBS Group's portfolio value rose 9.9% quarter-over-quarter to $349B.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.